Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Intangibles (2020 - 2025)

Historic Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $185.9 million.

  • Maravai Lifesciences Holdings' Intangibles fell 791.74% to $185.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $185.9 million, marking a year-over-year decrease of 791.74%. This contributed to the annual value of $195.0 million for FY2024, which is 1177.9% down from last year.
  • According to the latest figures from Q3 2025, Maravai Lifesciences Holdings' Intangibles is $185.9 million, which was down 791.74% from $193.1 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Intangibles ranged from a high of $241.6 million in Q1 2023 and a low of $117.6 million during Q4 2021
  • Moreover, its 5-year median value for Intangibles was $207.2 million (2024), whereas its average is $198.0 million.
  • In the last 5 years, Maravai Lifesciences Holdings' Intangibles plummeted by 3382.1% in 2021 and then skyrocketed by 8428.27% in 2022.
  • Maravai Lifesciences Holdings' Intangibles (Quarter) stood at $117.6 million in 2021, then surged by 84.28% to $216.7 million in 2022, then rose by 2.0% to $221.0 million in 2023, then dropped by 11.78% to $195.0 million in 2024, then dropped by 4.66% to $185.9 million in 2025.
  • Its last three reported values are $185.9 million in Q3 2025, $193.1 million for Q2 2025, and $199.6 million during Q1 2025.